These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 19187072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HIV/hepatitis C co-infection and hepatic fibrosis: looking beyond HIV-associated immune suppression; the contribution of hepatic steatosis and insulin resistance.
    Bhagani S.
    Gut; 2009 Dec; 58(12):1579-81. PubMed ID: 19923343
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Steatosis in hepatitis C: the missing link to metabolic abnormalities?
    Zein NN, Poterucha JJ.
    Am J Gastroenterol; 2006 Nov; 101(11):2616-8. PubMed ID: 17090285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F, Clément S.
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [Abstract] [Full Text] [Related]

  • 8. Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease.
    Targher G, Zoppini G, Muggeo M.
    Gut; 2008 Mar; 57(3):426; author reply 426-7. PubMed ID: 18268061
    [No Abstract] [Full Text] [Related]

  • 9. Steatosis in chronic hepatitis C: friend or foe?
    Negro F.
    Liver Int; 2008 Mar; 28(3):294-6. PubMed ID: 18290771
    [No Abstract] [Full Text] [Related]

  • 10. [Hepatitis C and insulin resistance].
    Seirafi M, Negro F.
    Rev Med Suisse; 2008 Sep 03; 4(169):1859-62. PubMed ID: 18831405
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Metabolic syndrome and NAFLD/NASH].
    Tamura Y, Sato F, Kawamori R.
    Nihon Rinsho; 2006 Dec 28; 64 Suppl 9():449-52. PubMed ID: 17458261
    [No Abstract] [Full Text] [Related]

  • 14. [Hepatitis C and metabolic syndrome].
    Aparcero López R, Campo JA, Romero-Gómez M.
    Gastroenterol Hepatol; 2010 Dec 28; 33(7):530-40. PubMed ID: 20206412
    [Abstract] [Full Text] [Related]

  • 15. Chronic hepatitis C infection and insulin resistance: two best friends.
    Abenavoli L, Almasio PL.
    Expert Rev Anti Infect Ther; 2011 Aug 28; 9(8):555-8. PubMed ID: 21819320
    [No Abstract] [Full Text] [Related]

  • 16. Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance.
    Bernsmeier C, Heim MH.
    Swiss Med Wkly; 2009 Nov 28; 139(47-48):678-84. PubMed ID: 20047129
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis C virus and glucose and lipid metabolism.
    Alaei M, Negro F.
    Diabetes Metab; 2008 Dec 28; 34(6 Pt 2):692-700. PubMed ID: 19195632
    [Abstract] [Full Text] [Related]

  • 18. [Steasis and hepatitis C].
    Hezode C, Castera L, Chouteau P, Dhumeaux D, Pawlotsky JM.
    Gastroenterol Clin Biol; 2003 Dec 28; 27(12):1091-5. PubMed ID: 14770109
    [No Abstract] [Full Text] [Related]

  • 19. [Nonalcoholic fatty liver disease and metabolic syndrome: equality of pathogenetic mechanisms and therapeutic approaches].
    Tkachenko EI, Uspenskiĭ IuP, Belousova LN, Petrenko VV.
    Eksp Klin Gastroenterol; 2008 Dec 28; (2):92-6. PubMed ID: 19145872
    [No Abstract] [Full Text] [Related]

  • 20. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.
    Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ.
    Scand J Gastroenterol; 2009 Dec 28; 44(6):752-9. PubMed ID: 19296398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.